Parkinson disease protein 7

PARK7 (Parkinson disease protein 7) is a multifunctional 189-amino acid protein that acts as an oxidative stress sensor and redox-sensitive chaperone (UniProt: Q99497). It performs diverse cellular protective roles including protein and nucleotide deglycation, repair of glycation damage, stabilization of neuroprotective proteins like NFE2L2 and PINK1, and regulation of mitochondrial morphology and autophagy. The protein also modulates NF-κB signaling and androgen pathways, and protects against hydrogen peroxide-induced cell death (UniProt: Q99497).

PARK7 is primarily implicated in Parkinson disease (PARK7, MIM 606324), but its functions have broader relevance to neurodegeneration through its roles in dopaminergic neuron protection, mitochondrial maintenance, and inflammatory regulation in astrocytes. Its capacity to prevent advanced glycation endproducts and maintain glucose homeostasis extends its relevance beyond the brain to pancreatic beta cell protection (UniProt: Q99497).

In Alzheimer's disease, PARK7 shows ambiguous regulation across subcellular fractions from post-mortem AD brain tissue, with a mean log2 fold-change of −0.023 relative to age-matched controls (Chaparral AD proteomics), suggesting minimal net change despite potential compartment-specific alterations. The protein's oxidative stress defense mechanisms remain potentially relevant to AD pathogenesis.